Newest Evie Ring feature is the first medical
journal trained AI companion in a wearable
PLEASANTON, Calif., Jan. 8, 2025
/PRNewswire/ -- Movano
Health (Nasdaq: MOVE) today announced the
latest enhancement to its Evie smart ring for women with the
beta release of EvieAI, the first wearable-based virtual wellness
assistant trained exclusively with data from medical journals. The
new feature enables Evie users to answer health questions quickly,
reliably and securely through the ring's companion app.
Planned future integration with Evie data will allow EvieAI's
responses to be personalized based on users' own health metrics,
including heart rate, blood oxygen, menstrual cycle information,
skin temperature variability, sleep, exercise and mood captured by
Evie's sensors and user logs.
Unlike general-purpose digital assistants like ChatGPT that are
trained using public data, EvieAI generates clear and concise
answers based on articles that have been published in over 100,000
medical journals and written by medical professionals. This
helps ensure accuracy and the ability to interpret complex user
queries about almost any symptom, disease, condition or
procedure.
Evie's new virtual assistant also follows industry-standard
encryption protocols to ensure that all user data, including
sensitive health information, is protected during storage and
transmission. This includes confidentiality protections ensuring
that chats cannot be traced back to individual users.
"Our vision for the Evie Ring has always been to provide
insights that can help users navigate their personal wellness
journeys," said Tyla Bucher, Chief
Marketing Officer at Movano Health. "EvieAI marks a significant
leap forward in helping us fulfill that vision."
Evie is the first smart ring designed with a small gap in the
ring surface and slight flex in the scratch-resistant metal to
accommodate daily fluctuations in finger size due to hormonal
changes and other variables, ensuring a comfortable fit at all
times. It has 4+ days of battery life, recharges in just 60 minutes
with the included charger, and is available exclusively through
www.eviering.com in gold, rose gold and silver finishes and in
sizes 5-12 with an optional complimentary sizing kit for those who
don't know their ring size. It costs $269 with no subscription fees.
The beta version of EvieAI is currently available for iOS only
and at no cost to existing Evie Ring customers.
About Movano Health
Founded in 2018, Movano
Inc. (Nasdaq: MOVE) dba Movano Health, maker of the Evie Ring
(www.eviering.com), is developing a suite of purpose-driven
healthcare solutions to bring medical-grade data to the forefront
of wearables. Featuring modern and flexible form factors, Movano
Health's devices offer an innovative approach to delivering trusted
data to both customers and enterprises, capturing a comprehensive
picture of an individual's health data and uniquely translating it
into personalized and intelligent insights.
Movano Health is developing its proprietary technologies and
wearable medical device solutions to enable the future use of data
as a tool to proactively monitor and manage health outcomes across
a number of patient populations that exist in healthcare. For more
information on Movano Health, visit https://movanohealth.com/.
Forward Looking Statements
This press release contains
forward-looking statements concerning our expectations,
anticipations, intentions, beliefs, or strategies regarding the
future. These forward-looking statements are based on assumptions
that we have made as of the date hereof and are subject to known
and unknown risks and uncertainties that could cause actual
results, conditions, and events to differ materially from those
anticipated. Therefore, you should not place undue reliance on
forward-looking statements. Examples of forward-looking statements
include, among others, statements we make regarding plans with
respect to the commercial launches of the Evie Ring and EvieMED
Ring; our expectations regarding potential commercial
opportunities; planned cost-cutting initiatives; anticipated FDA
clearance decisions with respect to our products; expected future
operating results; product development and features, product
releases, clinical trials and regulatory initiatives; our
strategies, positioning and expectations for future events or
performance. Important factors that could cause actual results to
differ materially from those in the forward-looking statements are
set forth in our most recent Annual Report on Form 10-K and any
subsequent Quarterly Reports on Form 10-Q, and in our other reports
filed with the Securities and Exchange Commission, including under
the caption "Risk Factors." Any forward-looking statement in
this release speaks only as of the date of this release. We
undertake no obligation to publicly update any forward-looking
statement, whether written or oral, that may be made from time to
time, whether as a result of new information, future developments
or otherwise.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/movano-health-launches-evieai-virtual-wellness-assistant-302344841.html
SOURCE Movano
